Three Infants Hospitalized in Three States as Federal and State Health Officials Investigate Possible Contamination in Nara Organics Whole Milk Organic Powdered Infant Formula

What Parker Waichman LLP Found

  • Three infants in California, Pennsylvania, and Washington developed confirmed infant botulism after consuming Nara Organics formula.
  • All three reported cases required hospitalization.
  • Federal regulators have advised parents to stop using the formula immediately.
  • FDA inspections reportedly identified deficiencies at manufacturing facilities involved in producing the formula.
  • Families affected by contaminated infant formula may have legal rights under product liability laws.

Federal health officials are investigating a potentially serious food safety issue involving Nara Organics Whole Milk Organic Powdered Infant Formula after three infants in different states developed infant botulism. The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), California Department of Public Health, and other state and local agencies are actively investigating the outbreak to determine whether contaminated powdered infant formula caused these illnesses.

The investigation centers on Nara Organics Whole Milk Organic Powdered Infant Formula distributed throughout the United States between July 2025 and June 2026. According to federal health authorities, three confirmed infant botulism cases have been identified in California, Pennsylvania, and Washington. All three infants reportedly consumed Nara Organics powdered formula before becoming ill. Each child required hospitalization.

Infant botulism is a rare but potentially life-threatening illness caused by toxins produced by the bacterium Clostridium botulinum. Because infants have immature digestive systems, they are particularly vulnerable to this dangerous toxin. When contamination occurs in food products intended for babies, the consequences can be severe and may require emergency medical intervention, prolonged hospitalization, and extensive follow-up care.

Federal officials have advised parents and caregivers to stop using the recalled product immediately while the investigation continues. Although testing remains ongoing, regulators have expressed sufficient concern to issue public warnings and begin tracing the supply chain involved in manufacturing and distributing the formula.

For families whose infants consumed this product, the outbreak raises significant concerns regarding product safety, quality control measures, manufacturing oversight, contamination prevention procedures, and whether preventable failures contributed to illnesses affecting vulnerable infants.

Understanding Infant Botulism and Why It Is So Dangerous

Infant botulism is one of the most serious foodborne illnesses that can affect young children. Unlike many foodborne illnesses that cause temporary gastrointestinal symptoms, botulism attacks the nervous system and can interfere with critical bodily functions.

The condition develops when Clostridium botulinum spores enter an infant’s digestive tract and produce a powerful neurotoxin. That toxin interferes with communication between nerves and muscles, causing progressive muscle weakness that can become life-threatening if breathing muscles are affected.

One reason infant botulism is especially dangerous is that symptoms may not appear immediately. According to health officials, symptoms can take days or even several weeks to develop following exposure. This delayed onset may make it difficult for parents to connect symptoms to a specific food source.

Common symptoms of infant botulism include:

  • Constipation
  • Poor feeding
  • Difficulty swallowing
  • Weak crying
  • Loss of head control
  • Reduced facial expressions
  • General muscle weakness
  • Difficulty breathing
  • Respiratory distress
  • Respiratory arrest

As symptoms worsen, affected infants may require hospitalization, respiratory support, intensive medical treatment, and long-term monitoring. In severe cases, botulism can be fatal.

Even when a child survives, families may face substantial medical expenses, emotional trauma, lost work time, and concerns about long-term developmental outcomes. These risks explain why federal agencies treat potential contamination involving infant formula with extraordinary seriousness.

What Federal Investigators Have Learned So Far

The FDA announced that its investigation remains in the early stages, but several important facts have already emerged.

Three confirmed infant botulism illnesses have been identified. Health officials reported that illness onset occurred between April and May 2026. All three affected infants consumed Nara Organics Whole Milk Organic Powdered Infant Formula before becoming sick.

Authorities have collected both opened and unopened formula samples for testing. State officials obtained leftover formula from affected households, while the FDA collected unopened containers from the same lot numbers associated with the illnesses.

Laboratory testing remains underway. Investigators hope that testing results will help determine whether contamination exists within specific formula lots and whether a direct connection can be established between the product and the illnesses.

Health officials have emphasized that this remains an active investigation. Additional information may emerge as testing, supply-chain reviews, and manufacturing evaluations continue.

The FDA has stated that parents should stop using the product immediately while investigators work to determine the source and extent of the contamination risk.

Manufacturing and Supply Chain Questions Raise Additional Concerns

One of the most significant developments in the investigation involves information uncovered during FDA traceback efforts.

Before learning about the reported illnesses, FDA inspectors had already conducted inspections at two European facilities involved in manufacturing Nara Organics infant formula. According to federal officials, both inspections resulted in observations identifying deficiencies at the facilities. The manufacturers subsequently submitted corrective action plans that remain under FDA review.

Investigators also discovered potential links involving suppliers connected to an earlier infant botulism outbreak.

The FDA determined that formula lots associated with the current outbreak were produced using milk supplied by Organic West Milk and spray-dried by Dairy Farmers of America. These same suppliers were connected to an earlier outbreak investigation involving ByHeart Powdered Infant Formula in late 2025.

At this time, regulators have not determined whether those suppliers are responsible for contamination in the current outbreak. However, the overlap has become an important focus of the investigation.

Further complicating matters, the FDA reported that Organic West Milk previously provided incomplete customer information during the earlier investigation. According to the agency, the supplier later acknowledged that information previously supplied to regulators should have included suppliers connected to Nara Organics formula production.

These developments raise important questions regarding supply-chain transparency, recordkeeping practices, contamination monitoring, and whether critical information may have been unavailable during prior investigations.

Why Powdered Infant Formula Contamination Cases Receive Intense Scrutiny

Infant formula occupies a unique place in the consumer marketplace. For many infants, formula serves as a primary or exclusive source of nutrition during critical stages of growth and development.

Because babies rely on these products daily, manufacturers are expected to maintain exceptionally strict quality control procedures. Even minor contamination events can expose infants to serious health risks.

When contamination occurs in powdered infant formula, investigators often examine:

  • Raw ingredient sourcing
  • Manufacturing practices
  • Environmental contamination controls
  • Equipment sanitation procedures
  • Product testing protocols
  • Storage conditions
  • Transportation methods
  • Supplier oversight systems
  • Recall procedures
  • Regulatory compliance history

Unlike many food products consumed occasionally, infant formula may be consumed multiple times each day. As a result, repeated exposure can increase risks when contamination is present.

Federal regulators often conduct extensive investigations to identify the root cause of contamination and determine whether additional products may be affected.

Potential Legal Claims Involving Contaminated Infant Formula

Families whose children develop serious illnesses after consuming contaminated infant formula may have legal rights under product liability laws.

Manufacturers, distributors, suppliers, and other parties involved in producing and marketing infant formula have a responsibility to provide products that are reasonably safe for their intended use.

When contamination causes injury, potential legal claims may include:

Defective Product Claims

A contaminated formula product may be considered defective if it contains dangerous substances that render it unsafe for infant consumption.

Negligence Claims

Families may allege that manufacturers, suppliers, or other responsible parties failed to exercise reasonable care in preventing contamination.

Failure to Warn Claims

If companies knew or should have known about contamination risks yet failed to provide adequate warnings, additional liability issues may arise.

Wrongful Death Claims

In cases where contaminated products result in fatal injuries, surviving family members may have grounds to pursue wrongful death litigation.

Medical Monitoring and Long-Term Injury Claims

Some infants may require ongoing medical evaluation and treatment after serious foodborne illnesses. Future medical expenses and long-term health consequences may become important factors in litigation.

Every case depends on individual facts, medical evidence, testing results, and findings from ongoing government investigations.

What Parents Should Do If Their Child Consumed Nara Organics Formula

Federal health officials have issued several recommendations for parents and caregivers.

Anyone currently using Nara Organics Whole Milk Organic Powdered Infant Formula should stop using the product immediately.

Parents should preserve evidence whenever possible. This includes:

  • Taking photographs of the formula container
  • Recording lot numbers
  • Recording expiration or use-by dates
  • Saving receipts if available
  • Keeping unopened containers
  • Preserving opened containers if advised by health officials

The FDA has recommended labeling remaining formula “DO NOT USE” and storing it separately for at least one month in case testing becomes necessary.

Parents should closely monitor children for symptoms consistent with infant botulism and seek immediate medical care if symptoms appear.

Prompt medical evaluation can be critical because infant botulism may progress rapidly once symptoms develop.

Nara Organic Formula Botulism Lawsuit FAQs

Can parents file a lawsuit if their child became ill after consuming Nara Organics formula?

Potentially yes. Families may have legal claims if medical evidence and investigation findings establish a connection between contaminated infant formula and their child’s illness. Product liability claims often focus on contamination, manufacturing defects, negligence, or failures in quality control procedures.

What compensation may be available in an infant formula contamination lawsuit?

Compensation may include medical expenses, hospitalization costs, future medical care, rehabilitation expenses, pain and suffering, emotional distress, lost income for caregivers, and other damages recognized under applicable law. Each case depends on the severity of the child’s injuries and other case-specific factors.

Does a child need a confirmed diagnosis of infant botulism to pursue a claim?

A diagnosis can be important evidence, but every situation is different. Families should preserve medical records, laboratory testing results, formula containers, lot numbers, and receipts. An attorney can evaluate whether sufficient evidence exists to investigate a potential claim.

Why is preserving the formula container important?

The container may contain lot numbers, manufacturing information, expiration dates, and other evidence that could become important during an investigation. Testing of remaining formula may also help identify contamination and establish links to specific production lots.

Who may be responsible in a contaminated infant formula lawsuit?

Liability may potentially extend to manufacturers, ingredient suppliers, distributors, processors, packaging companies, and other entities involved in producing and selling the product. Determining responsibility often requires a detailed investigation of the supply chain.

What if my child consumed the formula but has not shown symptoms?

Parents should continue monitoring their child and follow guidance from healthcare providers and public health authorities. Because symptoms can take time to develop, maintaining records of the product and monitoring health conditions may be important.

Are class actions possible in infant formula contamination cases?

The structure of litigation depends on the facts of the outbreak and the injuries involved. Some cases proceed individually, while others may involve coordinated litigation. The appropriate legal approach varies depending on the circumstances.

Free Consultation for Families Concerned About the Nara Organics Infant Formula Outbreak

Parents trust infant formula manufacturers to provide safe products for their children. When contamination concerns arise involving products intended for newborns and infants, families deserve answers regarding how the contamination occurred and whether it could have been prevented.

If your child consumed Nara Organics Whole Milk Organic Powdered Infant Formula and later developed symptoms consistent with infant botulism or another serious illness, it may be important to understand your legal rights.

Parker Waichman LLP is investigating potential claims involving contaminated infant formula and foodborne illness injuries. The firm offers free consultations to families seeking information about possible legal claims.

Call 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.

SHARE:
Free Consultation

Parker Waichman LLP

Untitled(Required)

CATEGORIES
Parker Waichman Reviews

4.8 from 549 Reviews

Related Testimonials

Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.

We Have Many Locations To Serve You
Serving Mass Tort Clients Nationally

We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.

Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
(516) 466-6500
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
(631) 390-0800
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
(212) 267-6700
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
(718) 469-6900
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
(718) 554-8055
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
(239) 390-1000
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
(973) 323-3603
Nationwide Service

We handle mass torts cases nationwide. Please contact our office to learn more.

Call Us